HealthFDA approves Rasonque for advanced pancreatic cancer

The US FDA approved Revolution Medicines’ Rasonque on Wednesday for advanced pancreatic cancer, creating a new option for patients with metastatic disease. A large trial found that the once-daily pill doubled survival rates, offering hope to people who have run out of other treatments.

pancreatic cancerRasonqueUS FDA

FFrance 24★★★☆☆2026-08-26 23:09Original